Merck vet Michael Rosenblatt joins R&D exodus to the startup world
Merck Chief Medical Officer Michael Rosenblatt recently caused quite a stir when he suggested that a lot of academic research work in the drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
